Belluscura plc Logo

Belluscura plc

BELL.L

(0.8)
Stock Price

12,36 GBp

-58.69% ROA

-43.91% ROE

-3.91x PER

Market Cap.

39.452.922,68 GBp

1.62% DER

0% Yield

-831.7% NPM

Belluscura plc Stock Analysis

Belluscura plc Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Belluscura plc Fundamental Stock Analysis
# Analysis Rating
1 DER

The stock has a minimal amount of debt (2%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

2 PBV

The stock's PBV ratio (1.81x) reflects a fair valuation, making it an attractive option for investors seeking balanced opportunities.

3 ROE

The stock's ROE indicates a negative return (-38.92%) on shareholders' equity, suggesting poor financial performance.

4 ROA

The stock's ROA (-58.69%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

5 Revenue Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

6 Net Profit Growth

Despite the passage of five years, this company's net profit has not shown any improvement, highlighting a lack of growth and making it a less appealing investment prospect.

7 Assets Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

8 Graham Number

The company's Graham number indicates that it is overvalued compared to its stock price, suggesting a potentially unfavorable investment opportunity.

9 Dividend Growth

The company's dividend growth has been flat for the past three years, raising concerns for potential investors seeking reliable returns.

10 Dividend

No dividends from the company in the past three years raises doubts about its profitability for shareholders.

11 Buffet Intrinsic Value

The company's stock presents a potential concern as it appears overvalued (0) by Warren Buffett's formula, indicating that its market price exceeds its estimated intrinsic value.

Belluscura plc Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Belluscura plc Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Hold
4 Stoch RSI Buy

Belluscura plc Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Belluscura plc Revenue
Year Revenue Growth
2018 245.554
2019 128.701 -90.79%
2020 0 0%
2021 420.316 100%
2022 1.398.082 69.94%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Belluscura plc Research and Development Expenses
Year Research and Development Expenses Growth
2018 0
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Belluscura plc General and Administrative Expenses
Year General and Administrative Expenses Growth
2018 546.673
2019 283.761 -92.65%
2020 435.676 34.87%
2021 2.724.257 84.01%
2022 2.470.268 -10.28%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Belluscura plc EBITDA
Year EBITDA Growth
2018 -624.546
2019 -1.451.711 56.98%
2020 -1.845.017 21.32%
2021 -5.126.980 64.01%
2022 -4.463.577 -14.86%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Belluscura plc Gross Profit
Year Gross Profit Growth
2018 -7.315
2019 14.316 151.1%
2020 0 0%
2021 -52.171 100%
2022 68.105 176.6%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Belluscura plc Net Profit
Year Net Profit Growth
2018 -1.478.177
2019 -1.544.829 4.31%
2020 -2.004.680 22.94%
2021 -5.030.641 60.15%
2022 -8.762.833 42.59%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Belluscura plc Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2018 0
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Belluscura plc Free Cashflow
Year Free Cashflow Growth
2018 -3.187.707
2019 -2.125.209 -49.99%
2020 -2.665.205 20.26%
2021 -10.131.147 73.69%
2022 -19.983.499 49.3%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Belluscura plc Operating Cashflow
Year Operating Cashflow Growth
2018 -2.383.440
2019 -1.002.377 -137.78%
2020 -1.470.773 31.85%
2021 -7.332.185 79.94%
2022 -14.906.368 50.81%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Belluscura plc Capital Expenditure
Year Capital Expenditure Growth
2018 804.267
2019 1.122.832 28.37%
2020 1.194.432 5.99%
2021 2.798.962 57.33%
2022 5.077.131 44.87%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Belluscura plc Equity
Year Equity Growth
2018 2.297.860
2019 3.727.929 38.36%
2020 30.156.932 87.64%
2021 24.672.492 -22.23%
2022 20.352.122 -21.23%
2023 25.201.292 19.24%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Belluscura plc Assets
Year Assets Growth
2018 2.550.610
2019 4.529.577 43.69%
2020 30.725.121 85.26%
2021 26.004.916 -18.15%
2022 23.598.342 -10.2%
2023 27.179.302 13.18%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Belluscura plc Liabilities
Year Liabilities Growth
2018 252.750
2019 801.648 68.47%
2020 568.189 -41.09%
2021 1.332.424 57.36%
2022 3.246.220 58.95%
2023 1.978.010 -64.12%

Belluscura plc Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0.01
Net Income per Share
-0.07
Price to Earning Ratio
-3.91x
Price To Sales Ratio
28.22x
POCF Ratio
-2.3
PFCF Ratio
-1.97
Price to Book Ratio
1.68
EV to Sales
26.99
EV Over EBITDA
-8.45
EV to Operating CashFlow
-2.53
EV to FreeCashFlow
-1.89
Earnings Yield
-0.26
FreeCashFlow Yield
-0.51
Market Cap
0,04 Bil.
Enterprise Value
0,04 Bil.
Graham Number
0.53
Graham NetNet
0.03

Income Statement Metrics

Net Income per Share
-0.07
Income Quality
1.83
ROE
-0.39
Return On Assets
-0.37
Return On Capital Employed
-0.31
Net Income per EBT
1
EBT Per Ebit
1.27
Ebit per Revenue
-6.55
Effective Tax Rate
0

Margins

Sales, General, & Administrative to Revenue
1.77
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0.16
Gross Profit Margin
-0.59
Operating Profit Margin
-6.55
Pretax Profit Margin
-8.32
Net Profit Margin
-8.32

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0.12
Free CashFlow per Share
-0.17
Capex to Operating CashFlow
0.34
Capex to Revenue
-3.63
Capex to Depreciation
-1.66
Return on Invested Capital
-0.53
Return on Tangible Assets
-0.59
Days Sales Outstanding
0
Days Payables Outstanding
698.71
Days of Inventory on Hand
2313.82
Receivables Turnover
0
Payables Turnover
0.52
Inventory Turnover
0.16
Capex per Share
-0.04

Balance Sheet

Cash per Share
0,02
Book Value per Share
0,17
Tangible Book Value per Share
0.1
Shareholders Equity per Share
0.17
Interest Debt per Share
0
Debt to Equity
0.02
Debt to Assets
0.01
Net Debt to EBITDA
0.38
Current Ratio
4.77
Tangible Asset Value
0,01 Bil.
Net Current Asset Value
0,01 Bil.
Invested Capital
0.02
Working Capital
0,01 Bil.
Intangibles to Total Assets
0.37
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
4370095
Debt to Market Cap
0.01

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Belluscura plc Dividends
Year Dividends Growth

Belluscura plc Profile

About Belluscura plc

Belluscura plc develops and commercialize oxygen related medical device products. The company offers X-PLO2R, a modular portable oxygen concentrator. Belluscura plc was incorporated in 2015 and is based in London, the United Kingdom.

CEO
Mr. Robert Rauker
Employee
24
Address
15 Fetter Lane
London, EC4A 1BW

Belluscura plc Executives & BODs

Belluscura plc Executives & BODs
# Name Age
1 Mr. Simon Neicheril
Chief Financial Officer & Director
70
2 Mr. Robert Fary
Senior Vice President of Global Sales & Executive Director
70
3 Mr. Jim Clement
Head of Commercial Strategy
70
4 Mr. Robert Rauker
Chief Executive Officer & Director
70
5 Mr. Keith Cook
Vice President of Operations
70

Belluscura plc Competitors

Tekcapital plc Logo
Tekcapital plc

TEK.L

(2.5)
Polarean Imaging plc Logo
Polarean Imaging plc

POLX.L

(1.0)
ANGLE plc Logo
ANGLE plc

AGL.L

(1.0)
Equals Group plc Logo
Equals Group plc

EQLS.L

(1.8)
Creo Medical Limited Logo
Creo Medical Limited

CREO.L

(0.8)